Salbutamol, a short acting beta-2 agonist, reduces risk and improves prognosis of prostate cancer
Preprint in medRxiv (February 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Preprint in medRxiv (February 2024)
Article in Oncogene (November 2023)
Article in Nucleic Acids Research (November 2023)